Organization
Department of Pharmacology & Experimental Therapeutics
6 abstracts
Abstract
Racial differences in the utilization of MRI-guided biopsy before prostate cancer diagnosis.Org: Division of Population Sciences, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Sidney Kimmel Medical College of Thomas Jefferson University, Sidney Kimmel Cancer Center at Jefferson Health, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA,
Abstract
Enzalutamide vs abiraterone in patients with prostate cancer with and without type 2 diabetes mellitus.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, College of Computing and Informatics,
Abstract
A comprehensive assessment of social determinants of health for metastatic breast cancer.Org: Sidney Kimmel Cancer Center at Thomas Jefferson University, Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University,
Abstract
Technology-enhanced acceleration of germline evaluation for therapy (TARGET): Results of a randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.Org: Yale Cancer Center, Yale School of Medicine, New Haven, CT, Yale School of Medicine, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University,
Abstract
Quality-of-life measurement in high-risk patients with uveal melanoma receiving adjuvant sunitinib or valproic acid.Org: Thomas Jefferson University, Division of Biostatistics, Department of Data Science, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, Department of Pharmacology & Experimental Therapeutics, Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center at Thomas Jefferson University,
Abstract
Preapproval medical products in patients with the diagnosis of metastatic uveal melanoma.Org: Sidney Kimmel Cancer at Jefferson Health, Sidney Kimmel Medical College at Thomas Jefferson University, NYU Grossman School of Medicine – Division of Medical Ethics, NYU Grossman School of Medicine- Division of Medical Ethics, Sidney Kimmel Cancer Center at Thomas Jefferson University,